HY000201

N/A

Report date: 2022/08/25 15:48:33

Base Information

Drug NameHY000201
Drug Alias NameHY-000201
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai HyaMab Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai HyaMab Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A